ClpQ

PF3D7_1230400 (ClpQ) is an ATP-dependent threonine protease of P. falciparum that provides proteolytic capacity essential for mitochondrial homeostasis and asexual blood-stage survival (PMID:17270290, PMID:22113196). Recombinant ClpQ displays threonine-protease, chymotrypsin-like, and peptidyl-glutamyl-peptide-hydrolase activities in vitro, each blocked by its cognate inhibitor, and the enzyme degrades a prokaryotic HslV substrate (GFP-Arc-repressor) when expressed in transgenic parasites, confirming proteolytic activity in vivo (PMID:17270290). ClpQ functions not as an isolated protease but as the peptidase subunit of the ClpQY complex, associating with the ClpY ATPase through a short C-terminal stretch of ClpY; a synthetic peptide mimicking this region disrupts the interaction (PMID:22113196). Antagonizing the ClpQ–ClpY interaction impairs parasite growth and maturation and triggers mitochondrial dysfunction — loss of membrane potential, activation of VAD-FMK-binding proteases and nucleases, and apoptosis-like death — establishing ClpQ's role in mitochondrial protein turnover and parasite viability (PMID:22113196, PMID:39245193). Localization evidence is discordant across the corpus: early fractionation and immunofluorescence placed ClpQ in the parasite cytosol (PMID:17270290), whereas a later analysis assigned it to the mitochondrion (PMID:30009761). The protein is expressed in a stage-restricted manner, detectable only in schizonts and merozoites (PMID:16616382). Beyond these findings, no structural model of the parasite complex or defined endogenous substrate has been characterized in the available corpus.

1. 2006 Medium

   Establishing when ClpQ protein is present across the intraerythrocytic cycle framed its likely window of action, showing it is a late-stage factor rather than a constitutively present housekeeping protease.

   Evidence Western blot across intraerythrocytic stages in P. falciparum

   PMID:16616382

   Open questions at the time

   • Does not address function or localization
   • Single method/single lab; no transcript-to-protein correlation
2. 2007 High

   Determining that recombinant ClpQ is enzymatically active answered whether the annotated protease is a functional peptidase, defining it as a threonine protease with multiple catalytic activities confirmed by inhibitor specificity and by degradation of a heterologous substrate in parasites.

   Evidence In vitro protease assays with recombinant protein plus inhibitor studies, and in-parasite GFP-Arc-repressor degradation; parallel fractionation/IFA localization

   PMID:17270290

   Open questions at the time

   • No endogenous parasite substrate identified
   • Cytosolic localization by this study conflicts with later mitochondrial assignment
   • Activities characterized on model/heterologous substrates only
3. 2011 Medium

   Identifying ClpY as ClpQ's partner and mapping the interaction to a short ClpY C-terminal region answered how ClpQ is assembled into a functional protease and provided a means to disrupt it, linking complex integrity to mitochondrial homeostasis and parasite survival.

   Evidence Interaction/binding characterization with synthetic C-terminal peptide competition; growth, mitochondrial membrane potential, and VAD-FMK protease/nuclease assays in P. falciparum

   PMID:22113196

   Open questions at the time

   • Phenotypes derive from peptide antagonism rather than genetic ablation of ClpQ itself
   • Stoichiometry and structure of the ClpQY complex not resolved
   • Mechanistic link between complex disruption and apoptosis-like death undefined
4. 2018 Low

   Reassessing ClpQ localization addressed the discrepancy over its subcellular site, assigning it to the mitochondrion in contrast to the earlier cytosolic report.

   Evidence In silico prediction plus immunoprecipitation/localization analysis cited in a review

   PMID:30009761

   Open questions at the time

   • Secondary review with no new primary localization experiment described
   • Directly contradicts the cytosolic finding of PMID 17270290
   • Import/targeting signal not experimentally defined
5. 2024 Medium

   Combining ClpQ pharmacological inhibition with PfPhb2 depletion under mitochondrial stress answered whether ClpQ contributes to mitochondrial protein quality control, showing that loss of its activity exacerbates mitochondrial ROS, membrane depolarization, and fission leading to apoptosis-like death.

   Evidence GlmS-inducible PfPhb2 knockdown combined with pharmacological ClpQ inhibition; growth, mitochondrial ROS, membrane potential, and morphology assays in P. falciparum

   PMID:39245193

   Open questions at the time

   • ClpQ role inferred via pharmacological inhibition, not direct genetic ablation
   • Inhibitor specificity for ClpQ not established
   • Direct substrates whose stabilization maintains mitochondrial integrity unknown

• The endogenous substrate repertoire of ClpQ, the structure of the parasite ClpQY complex, and its definitive subcellular localization remain unresolved.
• No native parasite substrate identified
• Localization conflict (cytosol vs mitochondrion) unresolved
• No genetic knockout of ClpQ reported; phenotypes rest on peptide or pharmacological disruption